Both drugs reduced the risk by approximately 50 percent.

Both drugs lower the risk of developing breast cancer by 50%.

Women who are at high risk now have a number of options.

The opportunity is to lower the cost of these drugs. The risk is that state Medicaid programs use this excuse to entirely deny some patients access to more effective and more expensive drugs which work for those patients.

The risk factors are the key reasons a person would use drugs. A kid could have all the information about drugs, but if they're not keyed in to the risk factors, they could still use. The regular school programs that incorporate drug education are not as intense as this one.

The most commonly used clinical application is drug reference, so far. But it has gone beyond just looking up drugs and dosages and running interaction checks.